Septerna
CA - South SFDiagnostics
Focus: Septerna is a GPCR-focused drug discovery company headquartered in South San Francisco, specializing in neurology therapeutics at an early clinical stage.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
7-3 this month
Stable — net -3 jobs in 30d
5 added, 8 removed. Backfill posture.
Should You Work at Septerna?
AI assessmentBest suited for early-stage biotech enthusiasts willing to accept clinical risk in exchange for scientific depth and optionality in a niche target class.
Why Work Here
- Deep scientific focus on GPCR biology, a validated but underexploited drug target class with high unmet need in neurology
- Early-stage position offers opportunity to shape platform and culture before scaling, with direct impact on drug discovery strategy
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SEP-631
Healthy VolunteersClinical Trials (1)
NCT07069036A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers
Phase 1Help build intelligence for Septerna
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.